MOSPD2 is a therapeutic target for the treatment of CNS inflammation

January 1, 2020
Clin Exp Immunol
https://pubmed.ncbi.nlm.nih.gov/32353176

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/32353176

Research summary

Key outcome of the study

Mouse model

TARGET:

Keywords

Technical specifications

Related products

Catalogue product

No items found.

Customized product

No items found.